Time filter

Source Type

Sanz-Marco E.,Polytechnic University of Mozambique | Gallego R.,Polytechnic University of Mozambique | Gallego R.,Biomedical Research Center for Rare Diseases Network | Diaz-Llopis M.,Polytechnic University of Mozambique | And 2 more authors.
Case Reports in Ophthalmology | Year: 2011

Introduction: Several therapeutic approaches have been developed to treat choroidal hemangioma. However, all these therapies are associated with a potential risk of damaging the overlying retina. Case Report: We report a case of circumscribed choroidal hemangioma (CCH) in a 59-year-old man refractory to laser treatment. Visual acuity was 20/200 and a serous macular detachment was present. The CCH was treated with oral propanolol, whereupon visual acuity improved to 20/20 and the macular detachment resolved without systemic or local adverse effects. Discussion: Propanolol is a β-blocker commonly used in cardiology that may induce endothelium vasoconstriction and inhibit endothelial proliferation. It has been shown to be effective in infantile facial hemangiomas, and proved safe and effective for the CCH in our patient. Further studies are needed to confirm our observation. Copyright © 2011 S. Karger AG, Basel.

Sanz-Marco E.,University of Valencia | Udaondo P.,University of Valencia | Garcia-Delpech S.,University of Valencia | Vazquez A.,University of Valencia | And 2 more authors.
Journal of Ocular Pharmacology and Therapeutics | Year: 2013

Purpose: We investigate the efficacy of 0.03% topical tacrolimus eyedrops for the treatment of dry eye in graft versus host disease (GVHD) patients resistant/intolerant to 0.05% topical cyclosporine. Methods: Forty-three patients were enrolled in this prospective study. After completing a 1-year run-in period of using artificial tears, 50% autologous serum eyedrops, and punctal plug occlusion, all the symptomatic patients (n=29) were treated with 0.05% topical cyclosporine (Restasis®; Allergan, Inc.). After 1 month, the patients who presented topical or systemic intolerance to cyclosporine were instructed to instill 0.03% topical tacrolimus once a day for 3 months (n=14). All the patients were allowed to continue with their basal dry eye treatment. Visual acuity, fluorescein staining, Schirmer test, fluorescein tear break-up time, and tear meniscus height measurement were evaluated fortnightly (minimum 3 months). Subjective assessments of symptoms were also reported at the beginning and at the end of the study. Results: Dry eye symptoms and signs improved statistically (P<0.05) and significantly with tacrolimus and cyclosporine topical treatment. No significant differences were observed between both the groups. The mean follow-up time was 12.14±2.69 months (range 10-18 months). Conclusion: The findings of this prospective pilot study suggest that cyclosporine-intolerant patients with dry eye associated with GVHD can be effectively treated with topical tacrolimus. © Mary Ann Liebert, Inc. 2013.

Sanz-Marco E.,University of Valencia | Lopez-Prats M.J.,University of Valencia | Garcia-Delpech S.,University of Valencia | Udaondo P.,University of Valencia | And 2 more authors.
Clinical Ophthalmology | Year: 2011

We report on a patient with hypovitaminosis A treated with autologous serum (AS) who had bilateral infectious ulcers positive for Haemophilus influenzae. The patient suffered a perforation of his right eye and total healing of his left eye with a residual leukoma. In cases of severe malnutrition, serum levels of vitamins and bacteriostatic and growth factors are reduced, so AS would not only be ineffective but also increase the risk of secondary corneal infection. The prophylactic use of a topical antibiotic would be useful in treatment with AS, especially in patients who do not use and adequately store the eye drops, as in our patient. © 2011 Sanz-Marco et al, publisher and licensee Dove Medical Press Ltd.

Discover hidden collaborations